Esophageal pH Testing in Patients Refractory to Proton Pump Inhibitor Therapy
BACKGROUND: Proton pump inhibitors (PPIs) are the most potent drugs available for the management of gastroesophageal reflux disease (GERD). Ambulatory 24 h pH monitoring is often recommended for patients experiencing symptoms despite PPI therapy. Recent pivotal data suggest that pH studies are predi...
Saved in:
Main Authors: | Barbara A MacKalski, Alexandra Ilnyckyj |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2008/862302 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of the Parameters of 24-Hours pH-Impedance and High-Resolution Esophageal Manometry in Patients with Barrett's Esophagus on Proton Pump Inhibitors
by: I. V. Maev, et al.
Published: (2023-06-01) -
Extraesophageal Reflux: What Is the Best Parameter for pH-Monitoring Data Analysis from the Perspective of Patient Response to Proton Pump Inhibitors?
by: Karol Zelenik, et al.
Published: (2013-01-01) -
New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01) -
Deprescribing proton pump inhibitors
by: Kim Jun Kevin Teh, et al.
Published: (2023-08-01) -
Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)